Recombinant Rat TIM-1/KIM-1/HAVCR Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 3689-TM
Key Product Details
Source
NS0
Accession #
Structure / Form
Monomer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Mouse myeloma cell line, NS0-derived rat TIM-1/KIM-1/HAVCR protein
Ser18-Val238, with a C-terminal 6-His tag
Ser18-Val238, with a C-terminal 6-His tag
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ser18
Predicted Molecular Mass
25.4 kDa
SDS-PAGE
55-65 kDa, reducing conditions
Activity
Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated human T cells.
Human T lymphocytes cultured for 72 hours with PHA were incubated for an additional 3 days in 96 well plates coated with 500 ng/mL anti‑CD3 and rrKIM-1.
The ED50 for this effect is 0.4‑2 µg/mL.
Optimal dilutions should be determined by each laboratory for each application.
Human T lymphocytes cultured for 72 hours with PHA were incubated for an additional 3 days in 96 well plates coated with 500 ng/mL anti‑CD3 and rrKIM-1.
The ED50 for this effect is 0.4‑2 µg/mL.
Optimal dilutions should be determined by each laboratory for each application.
Scientific Data Images for Recombinant Rat TIM-1/KIM-1/HAVCR Protein, CF
Recombinant Rat TIM-1/KIM-1/HAVCR Protein Bioactivity
Recombinant Rat TIM-1/KIM-1/HAVCR (Catalog # 3689-TM) inhibits anti-CD3-induced proliferation of stimulated human T cells. Human T cells cultured for 72 hours with PHA were incubated for an additional 3 days in 96 well plates coated with 500 ng/mL anti‑CD3 and Recombinant Rat TIM-1/KIM-1/HAVCR. The ED50 for this effect is 0.4‑2 µg/mL.Formulation, Preparation and Storage
3689-TM
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution |
Reconstitute at 100 μg/mL in sterile PBS.
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: TIM-1/KIM-1/HAVCR
KIM-1 (Kidney-injury molecule-1; also TIM-1 and HAVCR) is a 50‑80 kDa, variably glycosylated, type I transmembrane glycoprotein that is a member of the TIM family of immunoglobulin superfamily molecules (1‑5). This gene family is involved in the regulation of Th1 and Th2‑cell-mediated immunity. In mouse, there are eight known TIM/KIM genes (# 1‑8) vs. only three genes in human (# 1, 3, 4) (1, 2, 5). It is unknown if the rat genome exactly parallels that of mouse. Rat KIM-1 is synthesized as a 307 amino acid (aa) precursor that contains a 21 aa signal sequence, a 214 aa extracellular domain (ECD), a 21 aa transmembrane segment and a 51 aa cytoplasmic domain (4). The ECD contains one V-type Ig-like domain and a mucin region characterized by multiple Thr-Ser-Pro motifs. The mucin region may undergo extensive O-linked glycosylation. The mouse KIM-1 gene is highly polymorphic and this may be reflected in rat (4, 6). In human, TIM-1 is known to circulate as a soluble form. It undergoes constitutive cleavage by an undefined MMP, releasing an 85 kDa soluble molecule (7). A similar process has now been described in rat (8). The ECD of rat KIM-1 is 50% and 81% aa identical to human and mouse KIM-1 ECD, respectively. The only two reported ligands for KIM-1 are TIM-4 and the hepatitis A virus (9, 10). However, others are believed to exist, and based on the ligand for TIM-3, one might be an S-type lectin (11). KIM-1 is found on CD4+ T cells and proximal renal tubular cells (4, 12). KIM-1 ligation induces T cell proliferation and promotes cytokine production (1, 11). In particular, it induces IL-4 production, and requires the KIM-1 cytoplasmic tyrosine phosphorylation motif (12). Alternatively, KIM-1 activation of TIM-4 induces cell cycle arrest (13).
References
- Meyers, J.H. et al. (2005) Trends Mol. Med. 11:1471.
- Kuchroo, V.K. et al. (2003) Nat. Rev. Immunol. 3:454.
- Mariat, C. et al. (2005) Phil. Trans. R. Soc. B 360:1681.
- Ichimura, T. et al. (1998) J. Biol. Chem. 273:4135.
- Kuchroo, V.K. et al. (2006) Adv. Immunol. 91:227.
- McIntire, J.J. et al. (2001) Nat. Immunol. 2:1109.
- Bailly, V. et al. (2002) J. Biol. Chem. 277:39739.
- Vaidya, V.S. et al. (2006) Am. J. Physiol. Renal Physiol. 290:F517.
- Feigelstock, D. et al. (1998) J. Virol. 72:6621.
- Zhu, C. et al. (2005) Nat. Immunol. 6:1245.
- Meyers, J.H. et al. (2005) Nat. Immunol. 6:455.
- de Souza, A.J. et al. (2005) Proc. Natl. Acad. Sci. USA 102:17113.
- Mesri, M. et al. (2006) Int. Immunol. 18:473.
Long Name
T Cell Immunoglobulin Mucin-1
Alternate Names
CD365, HAVCR1, KIM-1, TIM1
Gene Symbol
HAVCR1
UniProt
Additional TIM-1/KIM-1/HAVCR Products
Product Documents for Recombinant Rat TIM-1/KIM-1/HAVCR Protein, CF
Product Specific Notices for Recombinant Rat TIM-1/KIM-1/HAVCR Protein, CF
This product is covered by one or more of the following US Patents 7,300,652; 7,041,290; 6,664,385 and other US and foreign patents pending or issued.
For research use only
Loading...
Loading...
Loading...